Skip to content
Catalyst

glycineFinding

Glycine has no detected effect on Scale for the Assessment of Negative Symptoms (SANS) total score

no difference foundVery limited evidenceFinding

01 · The sentence it was drawn from

“There were no significant differences in change in the SANS total score between glycine and placebo subjects or D-cycloserine and placebo subjects.”
Quoted verbatim from The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
This finding among the 1 finding on its endpoint

glycine

Scale for the Assessment of Negative Symptoms (SANS) total score

no difference found

Who
Inpatients and outpatients with schizophrenia or schizoaffective disorder and moderate to severe negative symptoms, adjunctive glycine against placebo; the D-cycloserine arm is a separate comparison against the same placebo
Dose studied
not reported

Very limited evidencePMID 17898352 · 2007

02 · The study

Study
RCT
Duration
4 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7EQF0PZ6WB2S8Q6NNSMWS7F